Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and Adolescents
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic (PK) profile; and safety and
tolerability of a single dose of tapentadol oral solution (OS) 1 mg/kg in children and
adolescents aged from 6 to less than 18 years with acute, moderate to severe postsurgical
pain.